First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design
published in: Future Oncology
date of publication: 2020-01-09
main subject: bevacizumab, colorectal cancer, metastatic colon cancer
Cites articles
There is nothing here
Article - wd:Q92500186